Displaying 1 - 1 of 1
| Active Ingredient | IMATINIB |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Chronic myeloid leukaemia, gastrointestinal stromal tumours . |
| Caution | Abdominal pain; appetite changes; arthralgia; ascites; conjunctivitis; constip ation; cough. |
| Dose Range | 400mg -600mg once a day .Maximum 800mg daily in divided doses. Take with food and plenty of water. |
| Drug Interactions | |
| Pregnancy | Use with caution during pregnancy. Adequate contraception is indicated. |
| Breast Feeding | Not recommended as Imatinib is excreted in breastmilk. |